BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2968886)

  • 1. Serum IGF-1 concentration in diabetic retinopathy.
    Hyer SL; Sharp PS; Brooks RA; Burrin JM; Kohner EM
    Diabet Med; 1988; 5(4):356-60. PubMed ID: 2968886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF I) during continuous subcutaneous insulin infusion (CSII).
    Hyer SL; Sharp PS; Sleightholm M; Burrin JM; Kohner EM
    Horm Metab Res; 1989 Jan; 21(1):18-22. PubMed ID: 2925151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatomedin-C and diabetic retinopathy.
    Sato K; Ikeda T; Miki T; Nishizawa Y; Morii H
    Jpn J Ophthalmol; 1988; 32(2):219-22. PubMed ID: 3184555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy.
    Lamberton RP; Goodman AD; Kassoff A; Rubin CL; Treble DH; Saba TM; Merimee TJ; Dodds WJ
    Diabetes; 1984 Feb; 33(2):125-9. PubMed ID: 6363166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor-I in diabetic retinopathy.
    Payne JF; Tangpricha V; Cleveland J; Lynn MJ; Ray R; Srivastava SK
    Mol Vis; 2011; 17():2318-24. PubMed ID: 21921983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy.
    Arner P; Sjöberg S; Gjötterberg M; Skottner A
    Diabetologia; 1989 Oct; 32(10):753-8. PubMed ID: 2591643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy.
    Hyer SL; Sharp PS; Brooks RA; Burrin JM; Kohner EM
    Metabolism; 1989 Jun; 38(6):586-9. PubMed ID: 2725298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.
    Tan K; Baxter RC
    J Clin Endocrinol Metab; 1986 Sep; 63(3):651-5. PubMed ID: 3734035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?
    Wang Q; Dills DG; Klein R; Klein BE; Moss SE
    Diabetes; 1995 Feb; 44(2):161-4. PubMed ID: 7859935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factors. Studies in diabetics with and without retinopathy.
    Merimee TJ; Zapf J; Froesch ER
    N Engl J Med; 1983 Sep; 309(9):527-30. PubMed ID: 6348545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy.
    Öberg D; Salemyr J; Örtqvist E; Juul A; Bang P
    Pediatr Diabetes; 2018 Aug; 19(5):972-978. PubMed ID: 29663652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy.
    Hyer SL; Sharp PS; Brooks RA; Burrin JM; Kohner EM
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):187-94. PubMed ID: 2916380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus.
    Merimee TJ; Gardner DF; Zapf J; Froesch ER
    Diabetes; 1984 Aug; 33(8):790-3. PubMed ID: 6378701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is insulinlike growth factor I associated with diabetic retinopathy?
    Dills DG; Moss SE; Klein R; Klein BE; Davis M
    Diabetes; 1990 Feb; 39(2):191-5. PubMed ID: 2227126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.
    Grant M; Russell B; Fitzgerald C; Merimee TJ
    Diabetes; 1986 Apr; 35(4):416-20. PubMed ID: 2420665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prorenin, IGF-I, IGF-binding proteins and retinopathy in diabetic patients.
    Elias AN; Pandian MR; Naqvi F; Sebag J; Charles MA; Gwinup G
    Gen Pharmacol; 1996 Mar; 27(2):329-32. PubMed ID: 8919651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes.
    Dills DG; Moss SE; Klein R; Klein BE
    Diabetes; 1991 Dec; 40(12):1725-30. PubMed ID: 1756914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
    Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
    Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decreased serum level of free bioavailable IGF-I in patients with diabetic retinopathy].
    Feldmann B; Lang GE; Arnavaz A; Jehle PM; Böhm BO; Lang GK
    Ophthalmologe; 1999 May; 96(5):300-5. PubMed ID: 10414118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatomedin on insulin-dependent diabetes mellitus.
    Cohen MP; Jasti K; Rye DL
    J Clin Endocrinol Metab; 1977 Aug; 45(2):236-9. PubMed ID: 885989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.